1. Home
  2. SNGX vs EDBL Comparison

SNGX vs EDBL Comparison

Compare SNGX & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • EDBL
  • Stock Information
  • Founded
  • SNGX 1987
  • EDBL 2020
  • Country
  • SNGX United States
  • EDBL United States
  • Employees
  • SNGX N/A
  • EDBL N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • EDBL Farming/Seeds/Milling
  • Sector
  • SNGX Health Care
  • EDBL Consumer Staples
  • Exchange
  • SNGX Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • SNGX 7.4M
  • EDBL 6.1M
  • IPO Year
  • SNGX 1987
  • EDBL 2022
  • Fundamental
  • Price
  • SNGX $2.35
  • EDBL $0.28
  • Analyst Decision
  • SNGX
  • EDBL
  • Analyst Count
  • SNGX 0
  • EDBL 0
  • Target Price
  • SNGX N/A
  • EDBL N/A
  • AVG Volume (30 Days)
  • SNGX 619.7K
  • EDBL 44.7M
  • Earning Date
  • SNGX 03-14-2025
  • EDBL 11-13-2024
  • Dividend Yield
  • SNGX N/A
  • EDBL N/A
  • EPS Growth
  • SNGX N/A
  • EDBL N/A
  • EPS
  • SNGX N/A
  • EDBL N/A
  • Revenue
  • SNGX $364,183.00
  • EDBL $14,069,000.00
  • Revenue This Year
  • SNGX N/A
  • EDBL $2.43
  • Revenue Next Year
  • SNGX $76.64
  • EDBL $42.42
  • P/E Ratio
  • SNGX N/A
  • EDBL N/A
  • Revenue Growth
  • SNGX N/A
  • EDBL 7.88
  • 52 Week Low
  • SNGX $1.83
  • EDBL $0.12
  • 52 Week High
  • SNGX $14.88
  • EDBL $12.47
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 34.04
  • EDBL 54.09
  • Support Level
  • SNGX $2.03
  • EDBL $0.21
  • Resistance Level
  • SNGX $3.44
  • EDBL $0.42
  • Average True Range (ATR)
  • SNGX 0.33
  • EDBL 0.05
  • MACD
  • SNGX -0.08
  • EDBL -0.01
  • Stochastic Oscillator
  • SNGX 19.39
  • EDBL 32.71

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: